|Articles|July 1, 2015
The Transition from Paper Records to Electonic Batch Records
Dennis Brandl, President, at BR&L Consulting, spoke with Pharmaceutical Technology about what should be expected when transitioning from paper to EBR.
Advertisement
Dennis Brandl, President, at BR&L Consulting, spoke with Pharmaceutical Technology about what should be expected when transitioning from paper to EBR.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
2
PharmTech Weekly Roundup—August 14, 2026
3
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
4
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
5